149 related articles for article (PubMed ID: 11874071)
1. Estrogen receptor expression in an endometrial stromal sarcoma after tamoxifen therapy.
Liao JB; Lin JY
Eur J Gynaecol Oncol; 2001; 22(6):417-9. PubMed ID: 11874071
[TBL] [Abstract][Full Text] [Related]
2. Endometrial stromal sarcoma expression of estrogen receptors, progesterone receptors and estrogen-induced srp27 (24K) suggests hormone responsiveness.
Navarro D; Cabrera JJ; León L; Chirino R; Fernández L; López A; Rivero JF; Fernández P; Falcón O; Jiménez P
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):589-96. PubMed ID: 1562530
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and progesterone receptors in uterine sarcomas.
Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE
Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
[TBL] [Abstract][Full Text] [Related]
4. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen.
Bergman L; Beelen ML; Gallee MP; Hollema H; Benraadt J; van Leeuwen FE
Lancet; 2000 Sep; 356(9233):881-7. PubMed ID: 11036892
[TBL] [Abstract][Full Text] [Related]
5. [The realization of the antiestrogen effect of tamoxifen in endometrial adenomatosis in women of reproductive age].
Putyrskaia NP; Chernukha GE
Akush Ginekol (Mosk); 1993; (6):43-6. PubMed ID: 8311158
[TBL] [Abstract][Full Text] [Related]
6. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
7. Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer.
Jordan VC
Breast Cancer Res Treat; 1995; 36(3):267-85. PubMed ID: 8573710
[TBL] [Abstract][Full Text] [Related]
8. Steroid hormone receptors in endometrial stromal sarcomas. A biochemical and immunohistochemical study.
Sabini G; Chumas JC; Mann WJ
Am J Clin Pathol; 1992 Mar; 97(3):381-6. PubMed ID: 1371902
[TBL] [Abstract][Full Text] [Related]
9. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
10. High-grade endometrial stromal sarcoma after treatment with tamoxifen in a patient treated for breast cancer.
Saga Y; Ohwada M; Kohno T; Takayashiki N; Suzuki M
Int J Gynecol Cancer; 2003; 13(5):690-2. PubMed ID: 14675357
[TBL] [Abstract][Full Text] [Related]
11. [Tamoxifen and endometrial pathology].
Negoiţă M; Terinte C; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen and endometrial cancer: new data for an old problem. Review.
Leo L; Tessarolo M; Febo G; Farina C; Nuzzo L; Arduino S; Wierdis T; Lanza A
Eur J Gynaecol Oncol; 1997; 18(5):429-33. PubMed ID: 9378170
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
[TBL] [Abstract][Full Text] [Related]
14. Effects of hormone therapy on the endometrium.
Deligdisch L
Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
[TBL] [Abstract][Full Text] [Related]
15. Effects of the new selective estrogen receptor modulator LY353381.HCl (Arzoxifene) on human endometrial cancer growth in athymic mice.
Dardes RC; Bentrem D; O'Regan RM; Schafer JM; Jordan VC
Clin Cancer Res; 2001 Dec; 7(12):4149-55. PubMed ID: 11751515
[TBL] [Abstract][Full Text] [Related]
16. [Changes in the endometrium after tamoxifen therapy].
Schmidt D
Pathologe; 2006 Feb; 27(1):27-32. PubMed ID: 16362260
[TBL] [Abstract][Full Text] [Related]
17. Targeted anti-estrogens to treat and prevent diseases in women.
Tonetti DA; Jordan VC
Mol Med Today; 1996 May; 2(5):218-23. PubMed ID: 8796891
[TBL] [Abstract][Full Text] [Related]
18. Risks and benefits of tamoxifen therapy.
Assikis VJ; Jordan VC
Oncology (Williston Park); 1997 Feb; 11(2 Suppl 1):21-3. PubMed ID: 9065923
[TBL] [Abstract][Full Text] [Related]
19. [Uterine sarcoma in patients receiving tamoxifen therapy. Apropos of 2 cases].
Le Bouëdec G; Auvray H; Curé H; de Latour M; Penault-Llorca F; Dauplat J
Rev Med Interne; 2001 Sep; 22(9):881-5. PubMed ID: 11599191
[TBL] [Abstract][Full Text] [Related]
20. Low-grade endometrial stromal sarcoma: hormonal aspects.
Chu MC; Mor G; Lim C; Zheng W; Parkash V; Schwartz PE
Gynecol Oncol; 2003 Jul; 90(1):170-6. PubMed ID: 12821359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
